Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07388420
Eligibility Criteria:
Inclusion Criteria:
* Age 18\~75 years
* Patients with HTG-AP
* Mixed hyperlipidemia
* Sign the informed consent form
Exclusion Criteria:
* Patients who have received lipid-lowering drugs or blood purification treatment
* Patients who have used evolocumab within one month before admission
* Patients who are accompanied by diseases that can seriously affect the survival
* Patients who have participated in the clinical research of other drugs within one month
* Patients who are pregnant or breastfeeding
* Patients with allergic asthma, allergic urticaria, eczema, and those who have a clear history of multiple drug and food allergies
* Other circumstances that researchers consider not suitable for participation in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07388420
Study Brief:
Protocol Section:
NCT07388420